Back to today’s briefing

Story perspectives

Breakthrough Enzyme Discovery Paves Way for Lyme Disease Treatments

3/22/2025

36 3

Summary

Story summary

Researchers at Virginia Commonwealth University have uncovered a vital enzyme, lactate dehydrogenase (BbLDH), essential for the survival of Borrelia burgdorferi, the bacteria responsible for Lyme disease. This breakthrough opens the door for innovative treatments, as two promising inhibitors, methoxsalen and medicarpin, demonstrate significant potential in curbing bacterial growth.

1 of 1

Story summary

Researchers at Virginia Commonwealth University have uncovered a vital enzyme, lactate dehydrogenase (BbLDH), essential for the survival of Borrelia burgdorferi, the bacteria responsible for Lyme disease. This breakthrough opens the door for innovative treatments, as two promising inhibitors, methoxsalen and medicarpin, demonstrate significant potential in curbing bacterial growth.